Skip to main content
. 2009 Dec 21;15(47):5966–5971. doi: 10.3748/wjg.15.5966

Figure 2.

Figure 2

Comparison of survival between the BDSR group and the pancreaticoduodenectomy (PD) group. A: The 3-year and 5-year overall survival rates were 51.7% and 36.6%, respectively, for the BDSR group and 46.0% and 38.1%, respectively, for the PD group; B: The 3-year and 5-year survival rates of the patients with stage Ia disease were 100.0% and 100.0%, respectively, for the BDSR group and 76.9% and 68.4%, respectively, for the PD group; C: The 3-year and 5-year survival rates of the patients with stage Ib disease were 55.8% and 32.6%, respectively, for the BDSR group and 59.3% and 59.3%, respectively, for the PD group; D: The 3-year and 5-year survival of patients with stage IIb disease were 19.2% and 19.2%, respectively, for the BDSR group and 31.9% and 14.2%, respectively, for the PD group.